Biotoscana Risk Report
Explore Biotoscana across six non‑financial risk dimensions:ESG, Workforce, News & Media, Cybersecurity, Legal & Regulatory, Operational. Unlock the full report, original sources and timelines, and enable continuous monitoring.
Summary
🛡️ Financial & Liquidity
Biotoscana has been involved in significant financial activities, primarily through acquisitions and IPOs, marking important events in its history. These activities suggest a strategy focused on expansion and consolidation within the Latin American market.
- Knight Therapeutics announced the acquisition of Grupo Biotoscana, establishing a growth platform in Latin America 🗓 October 21, 2019.
- Knight Therapeutics described its acquisition as 'transformational' for its operations in Brazil 🗓 October 31, 2019.
- Biotoscana had its IPO alongside Carrefour's Brazil unit, marking a successful entry into the Brazilian market 🗓 July 21, 2017.
⚖️ Legal & Regulatory
Knight Therapeutics has actively pursued regulatory milestones, particularly in Brazil and Mexico, signaling strategic compliance efforts following their acquisition of Biotoscana. These regulatory submissions and approvals illustrate the company's targeted approach to expanding its pharmaceutical offerings across Latin America.
- Knight Therapeutics announced regulatory submission of Fostamatinib in Brazil 🗓 February 21, 2024.
- Knight Therapeutics obtained regulatory approval for Tavalisse® in Mexico 🗓 December 12, 2024.
📜 Innovation & R&D
The company's focus on innovation is evident through its active R&D and regulatory submissions, strengthening its market position and product offerings. This indicates ongoing investment in developing and launching new pharmaceutical products across key Latin American markets.
- Knight Therapeutics announced the launch of Minjuvi® (tafasitamab) in Mexico, highlighting ongoing innovation efforts 🗓 March 26, 2025.
Profile
News & Media
Real‑time aggregation of trusted sources tracking company‑related events with sentiment and topic tags for rapid risk triage.
Sign up to unlock Biotoscana’s complete news feed with sentiment and topic tags.
View Full ReportEntity List
Continuous third‑party screening across global sanctions, enforcement, and watchlist sources with unified entity resolution and real‑time alerts.
| Name | Issuer | Status |
|---|---|---|
| ACF List of War Enablers | Anti-Corruption Foundation | |
| African Development Bank Debarred Entities | African Development Bank Group | |
| Argentina Members of Parliament | Honorable Cámara de Diputados de la Nación Argentina | |
| Argentina RePET Sanctions | Ministerio de Justicia | |
| Armenia Public Officials and Associates | Hetq Online | |
| Asian Development Bank Sanctions | Asian Development Bank | |
| Australian Sanctions Consolidated List | Department of Foreign Affairs and Trade | |
| Democratic People's Republic Of Korea (North Korea) Sanctions Regime | Department of Foreign Affairs and Trade | |
| Former Federal Republic Of Yugoslavia Sanctions Regime | Department of Foreign Affairs and Trade | |
| Iran Sanctions Regime | Department of Foreign Affairs and Trade |
Sign up to unlock Biotoscana’s sanctions, enforcement, and watchlist risk profile.
View Full ReportESG
Verification of declared ESG commitments and certifications with evidence links, score signals, and status updates across E, S, and G.
| Name | Status |
|---|---|
| Sustainable Finance Disclosure Regulation | |
| Global Reporting Initiative Standards | |
| EU Taxonomy Regulation | |
| EU Corporate Sustainability Reporting Directive | |
| California Transparency in Supply Chains Act | |
| EU Non-Financial Reporting Directive | |
| ISO 14001 | |
| Sustainability Accounting Standards Board Standards | |
| Task Force on Climate-related Financial Disclosures | |
| UN Guiding Principles on Business and Human Rights |
Sign up to unlock Biotoscana’s ESG commitments, certifications, and controversy signals.
View Full ReportCybersecurity
Verification of adherence to recognized security standards, mapping control coverage and gaps affecting third‑party and supply‑chain risk.
| Certification | Status |
|---|---|
| General Data Protection Regulation | |
| Digital Operational Resilience Act | |
| Cybersecurity Maturity Model Certification | |
| NIST Cybersecurity Framework | |
| NIST 800-53 Revision 5 | |
| California Consumer Privacy Act | |
| ISO/IEC 27001 | |
| Health Insurance Portability and Accountability Act | |
| Payment Card Industry Data Security Standard | |
| Federal Information Security Modernization Act |
Sign up to unlock Biotoscana’s security standards, control gaps, and exposure risks.
View Full ReportGet Biotoscana's full Non-Financial Risk Report
By signing up, you agree to our Terms and Privacy Policy.